Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Summit Therapeutics Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 91 | 95 | +4 |
| Shares | 32.3M | 32.4M | +69.6K (+0.2%) |
| Value | $60.4M | $84.4M | +$24.1M (+39.9%) |
New holders (10)
Institutions that held Summit Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Trust Advisors LP | 170,189 | $444.2K | 0.00% |
| Susquehanna Portfolio Strategies, LLC | 137,071 | $357.8K | 0.01% |
| Jane Street Group, LLC | 109,367 | $285.4K | 0.00% |
| Aristides Capital LLC | 80,601 | $210.4K | 0.11% |
| American Century Companies Inc | 77,074 | $201.2K | 0.00% |
| Bank of Montreal | 26,300 | $74.7K | 0.00% |
| Virtu Financial LLC | 16,526 | $43.0K | 0.00% |
| Wealth Management Partners, LLC | 15,000 | $39.1K | 0.02% |
| HighTower Advisors, LLC | 11,950 | $31.0K | 0.00% |
| LM Advisors LLC | 6,206 | $16.2K | 0.00% |
Sold out (6)
Institutions that held Summit Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Baker Bros. Advisors LP | 3,140,473 | $5.87M |
| Group One Trading, L.P. | 33,074 | $61.8K |
| AQR Capital Management LLC | 19,225 | $36.0K |
| Victory Capital Management Inc | 12,267 | $22.9K |
| Nisa Investment Advisors, LLC | 90 | $168 |
| Allworth Financial LP | 64 | $120 |